Evidence map›Paper›PMID 38831719›Full record

ArticleNeuro-oncology2024

Disturbance in cerebral blood microcirculation and hypoxic-ischemic microenvironment are associated with the development of brain metastasis.

Jenny Roesler, Daniel Spitzer, Xiaoxiong Jia, Synnøve Nymark Aasen, Kathleen Sommer, Bastian Roller, Niels Olshausen, Nils R Hebach, Nawid Albinger, Evelyn Ullrich and 12 more

Abstract read
In one paragraph

Article in Neuro-oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Molecular Underpinnings of Brain Metastases.International journal of molecular sciences · 2025
    Review
  13. Neurooncology: 2025 update.Free neuropathology · 2025
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Jenny RoeslerGoethe University, University Hospital, Institute of Neurology (Edinger Institute), Frankfurt, Germany.
Daniel SpitzerGoethe University, University Hospital, Institute of Neurology (Edinger Institute), Frankfurt, Germany.
Xiaoxiong JiaTianjin Neurosurgical Institute, Tianjin Huanhu Hospital, Tianjin, China.
Synnøve Nymark AasenDepartment of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.
Kathleen SommerGoethe University, University Hospital, Institute of Neurology (Edinger Institute), Frankfurt, Germany.
Bastian RollerGoethe University, University Hospital, Dr. Senckenberg Institute for Neurooncology, Frankfurt, Germany.
Niels OlshausenClinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Nils R HebachClinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Nawid AlbingerFrankfurt Cancer Institute (FCI), Frankfurt, Germany.
Evelyn UllrichFrankfurt Cancer Institute (FCI), Frankfurt, Germany.
Ling ZhuGoethe University, University Hospital, Institute of Neurology (Edinger Institute), Frankfurt, Germany.
Fan WangGoethe University, University Hospital, Institute of Neurology (Edinger Institute), Frankfurt, Germany.
Jadranka MacasGoethe University, University Hospital, Institute of Neurology (Edinger Institute), Frankfurt, Germany.
Marie-Therese ForsterDepartment of Neurosurgery, Goethe University, University Hospital, Frankfurt, Germany.ORCID 0000-0001-7055-543X
Joachim P SteinbachGerman Cancer Research Centre (DKFZ), Heidelberg, Germany.
Lisa SevenichInstitute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Frankfurt, Germany.
Kavi DevrajGoethe University, University Hospital, Institute of Neurology (Edinger Institute), Frankfurt, Germany.
Frits ThorsenDepartment of Biomedicine, Molecular Imaging Center, University of Bergen, Bergen, Norway.ORCID 0000-0002-7762-3703
Matthia A KarremanNeurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
Karl H PlateGerman Cancer Research Centre (DKFZ), Heidelberg, Germany.
Yvonne ReissGerman Cancer Research Centre (DKFZ), Heidelberg, Germany.
Patrick N HarterCenter for Neuropathology and Prion Research, Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.ORCID 0000-0001-5530-6910

Funding

Deutsche Krebshilfe 70112507
6 · The paper itself

Abstract

backgroundBrain metastases (BM) constitute an increasing challenge in oncology due to their impact on neurological function, limited treatment options, and poor prognosis. BM occurs through extravasation of circulating tumor cells across the blood-brain barrier. However, the extravasation processes are still poorly understood. We here propose a brain colonization process which mimics infarction-like microenvironmental reactions, that are dependent on Angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF).

methodsIn this study, intracardiac BM models were used, and cerebral blood microcirculation was monitored by 2-photon microscopy through a cranial window. BM formation was observed using cranial magnetic resonance, bioluminescent imaging, and postmortem autopsy. Ang-2/VEGF targeting strategies and Ang-2 gain-of-function (GOF) mice were employed to interfere with BM formation. In addition, vascular and stromal factors as well as clinical outcomes were analyzed in BM patients.

resultsBlood vessel occlusions by cancer cells were detected, accompanied by significant disturbances of cerebral blood microcirculation, and focal stroke-like histological signs. Cerebral endothelial cells showed an elevated Ang-2 expression both in mouse and human BM. Ang-2 GOF resulted in an increased BM burden. Combined anti-Ang-2/anti-VEGF therapy led to a decrease in brain metastasis size and number. Ang-2 expression in tumor vessels of established human BM negatively correlated with survival.

conclusionsOur observations revealed a relationship between disturbance of cerebral blood microcirculation and brain metastasis formation. This suggests that vessel occlusion by tumor cells facilitates brain metastatic extravasation and seeding, while combined inhibition of microenvironmental effects of Ang-2 and VEGF prevents the outgrowth of macrometastases.

Indexed as

Angiopoietin-2Brain NeoplasmsMicrocirculationTumor MicroenvironmentVascular Endothelial Growth Factor AAnimalsBlood-Brain BarrierCerebrovascular CirculationFemaleHumansMaleMiceMice, Inbred C57BLAngiopoietin-2Vascular Endothelial Growth Factor Aangiopoietin-2anti-angiogenic therapybrain metastasesperivascular nicheVEGF

Identifiers

PMID38831719
PMCPMC11534324

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.